Advertisement

Pediatric Nephrology

, Volume 21, Issue 7, pp 1031–1033 | Cite as

Steroid sparing effect of a herbal preparation in steroid-dependent nephrotic syndrome

  • Arpana Iyengar
  • Hrishikesh Damle
  • Chanda Kulkarni
  • Latha Damle
  • Kishore PhadkeEmail author
Brief Report

Abstract

Investigations on plants are revealing the potential therapeutic benefits of medicinal herbs in treating immunological disorders. Nephrotic syndrome has emerged as an immunological disorder. Steroid dependence poses a therapeutic challenge in the management of nephrotic syndrome. Our pilot study compares the efficacy of an ayurvedic polyherbal preparation ‘Shathavaryadi Yoga (NS001)' with oral cyclophosphamide in maintaining remission in steroid-dependent nephrotic syndrome.

Keywords

Cyclophosphamide Cyclosporine Herbal medicines 

References

  1. 1.
    Donia AF, Ammar HM, El-Agroudy AEB, Moustafa FEH, Sobh MAK (2005) Long term results of two unconventional agents in steroid dependent nephrotic children. Pediatr Nephrol 20:1420–1425CrossRefGoogle Scholar
  2. 2.
    Novak I, Frank R, Vento S, Vergara M, Gauthier B, Trachtman H (2005) Efficacy of MMF in pediatric patients with steroid dependant Nephrotic Syndrome. Pediatr Nephrol 20:1265–1268CrossRefGoogle Scholar
  3. 3.
    Kausman JY, Yin L, Jones CL, Johnston L, Powell HR (2005) Vincristine treatment in steroid dependent Nephrotic Syndrome. Pediatr Nephrol 20:1416–1419CrossRefGoogle Scholar
  4. 4.
    Latta K, von Schnakenburg C, Ehrich JH (2001) A Meta analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16:271–282CrossRefGoogle Scholar
  5. 5.
    Lui XY (1995) Therapeutic effect of chai-ling-tang (sairei-to) on steroid dependent nephrotic syndrome in children. Am J Chinese Med 23:255–260CrossRefGoogle Scholar
  6. 6.
    Dahanukar SA, Kulkarni RA, Rege NN (2000) Pharmacology of medicinal plants and natural products. Indian J Pharmacol 32:S81–S118Google Scholar
  7. 7.
    (1974) Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children. Lancet 24:423–427Google Scholar
  8. 8.
    Bakr A, Shokeir M, El-Chenawi F, El-Husseni F, Abdel-Rahman A, El-Ashry R (2003) TNF α production from mononuclear cells in nephrotic syndrome. Pediatr Nephrol 18:516–520Google Scholar
  9. 9.
    Zachwieja J, Bobkowski W, Zaniew M, Lewandowska-Stachowiak M, Siwinska A (2003) Apoptosis and antioxidant defense in nephrotic syndrome. Pediatr Nephrol 18:1116–1121CrossRefGoogle Scholar
  10. 10.
    Kapil A, Sharma S (1997) Immunopotentiating compounds from Tinospora cordifolia. J Ethnopharmacol 58:89–95CrossRefGoogle Scholar
  11. 11.
    Dhawan BN, Patnaik GK, Rastogi RP, Singh KK, Tandon JS (1977) Screening of Indian plants for biological activity. Indian J Exp Biol 15:208–219PubMedGoogle Scholar
  12. 12.
    Ram A (1996) Effect of Zeylanica plumbago in hyperlipidemia in rabbits and its modification by vit E. Indian J Pharmacol 28:161–166Google Scholar

Copyright information

© IPNA 2006

Authors and Affiliations

  • Arpana Iyengar
    • 1
  • Hrishikesh Damle
    • 3
  • Chanda Kulkarni
    • 2
  • Latha Damle
    • 3
  • Kishore Phadke
    • 1
    Email author
  1. 1.Childrens’ Kidney Care Center, Department of PaediatricsSt Johns Medical College HospitalBangaloreIndia
  2. 2.St Johns Medical CollegeBangaloreIndia
  3. 3.ATRIMED PharmaBangaloreIndia

Personalised recommendations